Cargando…
IS THERE ANY DIFFERENCE IN THE PROGNOSIS FOR PATIENTS WITH PRIMARY OSTEOSARCOMA WITH A POOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY BETWEEN HUVOS GRADES I AND II?
Would there be any difference in the prognosis for patients who presented, for example, 8% or 88% tumor necrosis induced by chemotherapy, even though both individuals were considered to be poor responders? The aim of this study was to compare the prognoses for different histological grades (Huvos gr...
Autores principales: | Bispo Júnior, Rosalvo Zósimo, Camargo, Olavo Pires de |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799283/ https://www.ncbi.nlm.nih.gov/pubmed/27027032 http://dx.doi.org/10.1016/S2255-4971(15)30256-1 |
Ejemplares similares
-
Prognostic Factors in the Survival of Patients Diagnosed with Primary Non-Metastatic Osteosarcoma with a Poor Response to Neoadjuvant Chemotherapy
por: Júnior, Rosalvo Zósimo Bispo, et al.
Publicado: (2009) -
Prognostic Factors and Expression of MDM2 in Patients with Primary Extremity Liposarcoma
por: Júnior, Rosalvo Zósimo Bispo, et al.
Publicado: (2008) -
Osteochondroma: ignore or investigate?()
por: de Souza, Antônio Marcelo Gonçalves, et al.
Publicado: (2014) -
Chronic Multiple Knee Ligament Injuries: Epidemiological Analysis of More Than One Hundred Cases
por: Bispo, Rosalvo Zosimo, et al.
Publicado: (2008) -
The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
por: Huang, Yujing, et al.
Publicado: (2021)